SINCE the early thirties of this century it has been known that chemical substances are involved in the transmission of impulses at the neuromuscular junction, in autonomic anglia and at autonomic effector endings. It was later shown that a number of chemical agents produce their actions in the body by interfering with the process of chemical transmission.
Loewi (1921) was the first to demonstrate that following stimulation of the vagus nerve to the heart, a specific chemical substance is released at the nerve endings. The vagus nerve to the heart was stimulated in the frog and the perfusate from the heart, when perfused through the heart of another frog, caused immediate cardiac arrest. Loewi termed this hypothetical chemical substance 'Vagustoff' and later identified it as acetylcholine. Release of a similar substance in the mammalian heart was demonstrated by Feldberg & Krayer (1933) . Dale, Feldberg & V gt (1936) later reported the release of acetylcholine at the neuromuscular junction following stimulation of motor nerves to skeletal muscle.
It is now well recognized that acetylcholine is liberated at parasympathetic nerve endings, autonomic ganglia and skeletal neuromuscular junctions. It is customary to divide the actions of acetylcholine into 'muscarinic' at the parasympathetic nerve endings and 'nicotinic' at the level of autonomic ganglia and at the skeletal neuromuscular junction, because these actions closely resemble those produced by the alkaloids muscarine and nicotine respectively. Oliver & Schafer (1895) (Paton, 1958; Gad- (Robson & Stacey, 1962) .
Fractionation studies with the ultracentrifuge have also assisted in the localization of the active substances (Whittaker, 1959 (Curtis, 1965) (MacIntosh & Oborin, 1953; Mitchell, 1963; Szerb, 1963) .
In the cerebellum, Purkinje cells are stimulated by acetylcholine (Phillis, 1965) , and in the granular layer some cells have also been found to be excitable to iontophoretically applied acetylcholine (McCance & Phillis, 1964 (Vogt, 1954 (Bradley & Wolstencroft, 1965) . In the cerebral cortex, the effects of dopamine and other catecholamines are always depressant in nature (Krnjevic & Phillis, 1963a (Curtis, 1965) . The acetylcholine sensitivity of these cells resembles that of sympathetic ganglia.
However, these cells differ in their responses to acetylcholine and acetyl-p-methylcholine. Dihydro-/3-erythroidin blocks the action of the former only, whereas atropine blocks the action of the latter without abrogating the former. It is possible, therefore, that both nicotinic as well as muscarinic types of actions are present in the CNS (Curtis & Ryall, 1964) . Transmission at the motor neurons and at the interneurons is more complex in nature and at these sites seems to be insensitive to acetylcholine.
In the brain stem, acetylcholine stimulates 35%
and inhibits 12% of the cells at a site within 3 mm from the midline (Bradley, Dhawan & Wolstencroft, 1964 (Brodie, Fletscher & Shore, 1955) . The original hypothesis of Hess has been revived and it has been postulated that in the brain there are two opposing types of systems for coordination of the somatomotor activity. One is called 'ergotrophic' which is activated by noradrenaline and leads to excitement and increased sympathetic activity, whereas the 'trophotropic' system is subserved by 5-HT, predominance of which causes parasympathetic stimulation and apathy (Brodie, Prockop & Shore, 1958) . This is an interesting example of the action of drugs in modifying the physiological actions of mediators. With modern techniques, further observations along these lines are expected.
Amino acids
The glutamate ion is a general excitant and y-amino butyric acid (GABA) is an inhibitory agent to the neurons of the CNS. These two substances are present in the brain and are effective even in low concentration. GABA is formed from glutamate by a process of decarboxylation. Jasper, Khan & Elliott (1965) have shown that in experimental animals the turnover of GABA was about three times more rapid when a sleep pattern of EEG was maintained, whereas in a continuous waking state no measurable GABA could be obtained in the perfusate. The roles of glutamate and GABA in the transport, metabolism and function of the neurons are closely interrelated and it has been suggested (Gaddum, 1965) that both compete for the same receptors although they have opposing actions.
The exact nature of these has yet to be elucidated.
Polypeptides
Substance P is a polypeptide with remarkable pharmacological properties and it has a specific distribution in the extracts of brain (Lembeck & Zetter, 1962) .
In cats, substance P leads to an impression of deep sedation on intraventricular administration. Similar results have been obtained in mice (Capek, 1963) . However, the physiological functions of substance P in the brain have not been clearly demarcated.
Ergothionine
Crossland (1960) and Crossland & Mitchell (1958) (Crossland, Woodruff & Mitchell, 1964 (Adam, 1961) . The histamine content of the pituitary gland and hypophyseal stalk is related to their mast cell content. Brain tissue proper does not contain mast cells. Adam & Hye (1964) observed that compound 48/80 lowered the histamine content of the pituitary gland and the hypophyseal stalk (i.e. mast-cell containing tissues), but not that of the thalamus and hypothalamus. In the latter sites, reserpine lowered the histamine content without affecting it in the former. In the brain both the synthesizing enzyme histidine decarboxylase and the catabolizing enzyme imidazole-N-methyl transferase are present. Methylation seems to be the principal pathway for the inactivation of histamine in the brain.
Electrophoretic administration of histamine in the CNS leads to inhibition of the neuronal activity in the cerebral cortex (Krnjevic & Phillis, 1963b imbalance presumably by altering the permeability of the cell membrane. The physiology of the central nervous system is thus at present being rewritten. This in its turn will lead to revision of our ideas about drug action on the central nervous system, and it is hoped that it may become possible to define the actions of drugs such as analgesics, hypnotics and tranquillizers in terms of specific transmitter release as is now possible for a number of substances acting on the peripheral nervous system.
